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Adriamycin-Fe3+ complex catalyzes the formation of hydroxyl radical from hydrogen peroxide but the 
DNA-adriamycin-iron ternary complex is much more effective. 1 1-Deoxyadriamycin, which shows no 
spectral evidence of complex formation with iron, was ineffective. The generation of hydroxyl radical by 
adriamycin-Fe3+ complex in the presence of DNA correlates with its ability to cleave DNA. Hydroxyl 
radicals are thus implicated as the reactive oxygen species involved in the DNA damage caused by the 
adriamycin-Fe3+ complex. 
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1. INTRODUCTION 
While it has been known for some time that the 
anthracycline antibiotics, daunomycin and adria- 
mycin, bind transition metal ions, it is only recent- 
ly that association constants for this interaction 
have been published [ 11. These studies revealed 
that adriamycin possesses a high affinity for Fe3+, 
with step association constants of lo”, lo”, and 
104.4. These values are high enough that adriamy- 
tin may be able to chelate iron in vivo. For this 
reason we have examined the biochemistry of 
adriamycin-iron complexes. We have shown that 
the adriamycin-iron complex can bind to erythro- 
cyte ghost membranes and in the presence of glu- 
tathione catalyze the oxidative destruction of these 
membranes [2]. In a separate study, we have been 
able to show that the adriamycin-iron chelate 
binds to DNA to form a ternary complex. As with 
the erythrocyte ghost, oxidative destruction of the 
DNA is initiated in the presence of glutathione [3]. 
In both situations, the destruction of the macro- 
molecular target first involves thiol-mediated re- 
duction of oxygen to hydrogen peroxide followed 
by subsequent reaction of hydrogen peroxide with 
the drug-metal complex which is responsible for 
the damage. In both cases, the hydroxyl radical 
scavengers, mannitol and DMSO, lessened the da- 
mage, albeit inefficiently, requiring much higher 
concentrations than normal. For these reasons, we 
have used the spin trapping of ‘OH to reexamine 
more definitively the role of hydroxyl radical in 
hydrogen peroxide-dependent DNA damage cata- 
lyzed by adriamycin-iron complex. The results 
show that while the adriamycin-Fe3+ complex can 
catalyze the production of hydroxyl radical, the 
DNA-adriamycin-iron ternary complex is more 
effective. 
2. MATERIALS AND METHODS 
Adriamycin HCl was supplied by the Drug 
Development Branch, Division of Cancer Treat- 
ment, National Cancer Institute, Bethesda, MD 
and 11-deoxyadriamycin HCl was a gift from Dr 
F.F. Arcamone, Farmitalia C. Erba, Milan. 
FeC13.6HzO (99.5% pure, Allied Chemicals) was 
the source of Fe3+. Hz02 (30%) was obtained 
from Fisher. Diethylenetriaminepentaacetic a id 
(DETAPAC) and the spin trap S$dimethyl-l-pyr- 
roline oxide (DMPO) were from Aldrich. DMPO 
was purified by two distillations before use. 
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Desferriox~ine mesylate (Desferal) was purchas- 
ed from Ciba. All reaction solutions and buffers 
were passed over Chelex-100 resin (Bio-Rad) 
before use. SV 40 [3H]DNA was supplied by 
Bethesda Research Laboratories and used without 
further purification. Highly polymerized caif 
thymus DNA (Sigma) for ESR studies was freed of 
metal ions by dialysis for 24 h against 0.1% 
DETAPAC followed by 48 h dialysis against metal 
ion-free buffer at 4°C [4]. 
2.1. ~pectrop~otom~tr~~ studies 
One pl aliquots of freshly prepared 2.5 mM 
aqueous FeCL was added to 6~1 of 5 mM adria- 
mycin or 1 1-deoxyadriamycin at -pH 2 to form a 
complex. The complex was then adjusted to pH 7.5 
with 1 ml of 20 mM NaCI, 10 mM Tris-HCi buf- 
fer immediateIy before recording the spectrum. 
The spectrum was recorded in 1 cm path-length 
cells on a Hewlett Packard 845OA diode array 
spectrophotometer equipped with a Hewlett 
Packard 7470A plotter and 89100A temperature 
controller. All spectrophotometric titrations were 
performed at 24°C. 
2.2. DNA cleavage reaction 
DNA degradation assay mixture consisted of 
O-1 mM HzOz, 0.25 pg (-5000 cpm) SV 40 
f3H]DNA (>95Yo form I) and 1OpM 1: 1 anthra- 
cycline-Fe3+ complex in a final volume of 1oOftI. 
The assay was performed in 20 mM NaCl, 10 mM 
Tris-HCl buffer (pH 7.5) and was initiated by ad- 
dition of the complex. Following 10 min incuba- 
tion at room temperature, the reaction was ter- 
minated by adding 0.25 mM Desferal, 1% SDS 
and adjusting the pH to 5.0 with HCI. Desferal 
and SDS stop the reaction by dissociating the ter- 
nary complex of DNA-drug-iron. Desferal 
chelates iron (affinity constant -1033) and prevents 
its involvement in additional redox catalysis while 
SDS prevents the freed anthracycline from inter- 
calating into DNA. At pH 5.0, the dissociation of 
the ternary complex is completed in less than 
1 min. 
2.3. Separation of DNA from the reaction 
components 
Gel filtration was used to separate DNA from 
the rest of the assay reactants. This step is essential 
because the presence of anthracyclines interferes 
with the estimation of nicked DNA by the nitro- 
cellulose filters. The assay mixture was applied to 
a prepacked Sephadex G-25 column (PDlO, Phar- 
macia) previously washed with SSC buffer (pH 
7.1). DNA was eluted with 4 ml of the same buf- 
fer. DNA recovery from the column was routinely 
greater than 95%. 
2.4. Estimation of nicked DNA 
The percentage of nicked DNA was quantitated 
after a denaturation-renaturation cycle using 
Schuller and Schneider BA 85 nitrocellulose filters 
IS]. These filters allow unnicked double-stranded 
DNA (form I) to pass through while retaining 
nicked (linear and circular) single-stranded DNA. 
Alkaline denaturation was achieved with 0.9 M 
NaCI, 0.1 M &HP04 and 0.025 M EDTA buffer 
adjusted to pH 12.15 with NaOH. HCl (2 M) was 
used for renaturation. Filters were dried at 60°C 
and then allowed to dissolve in hydrofluor (Na- 
tional Diagnostics) scintillation liquid prior to 
counting. Filter counts (nicked DNA) were ex- 
pressed as a percentage of total counts in the assay. 
2.5. Hydroxyl radical assay 
Hydroxyl radical formation was assayed by ESR 
spectrometry using DMPO as a spin-trapping 
agent. A Varian E-104 spectrometer operating at 
X-band (9.5 GHz) and employing 100 kHz modu- 
lation was used for ESR measurements. The assay 
mixture in 20 mM NaCl, 10 mM Tris-HCI buffer 
(pH 7.5) contained 1OpM 1: 1 anthracycline-Fe3+ 
complex, lOO~g/ml calf thymus DNA and 100 
mM DMPO. The reaction was started by adding 
9OaM Hz02 and followed for 15 min at room 
temperature (24°C). 
3. RESULTS AND DISCUSSION 
Spectral evidence for adriamycin-Fe3+ complex 
formation was reported in [Z]. This was character- 
ized by a marked loss in the absorption at 480 nm 
and the appearance of a new band between 580 and 
610 nm in association with two clearly defined 
isosbestic points at 430 and 535 nm. Whereas the 
addition of FeCls to adriamycin produced spectral 
changes indicative of adriamycin- Fe3+ comp1ex 
formation as reported, no spectral evidence of 
complex formation was observed with 1 l-deox- 
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Fig. 1, Structures of adriamycin and 11 -deoxyadriamycin. 
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yadriamycin (fig.2A,B). The removal of the Ctt- 
hydroxy group of adriamycin is thus associated 
with complete loss of iron binding to the drug 
chromophore. Because of this observation we have 
used I 1-deoxyadriamycin as a control to study the 
chemistry of the H20z-dependent DNA cleavage 
reaction catalyzed by adriamycin-Fe3+ complex. 
As apparent from fig.3, the 1: 1 adriamycin- 
Fe3* complex causes HzOz-dependent DNA de- 
gradation. The concentration of Hz02 required to 
ADRIAMYCIN 
1 400 450 500 550 600 650 700 ; 
WAVELENGTH lnml 
cleave 5OVo of the DNA was 1 FM. In contrast, the 
1 l-deoxyadri~ycin-Fe3’ mixture was much less 
effective. Fe3+ even in the presence of 1 mM Hz02 
caused less than 5% damage of the DNA. Adria- 
mycin and 11-deoxyadriamycin i  the absence of 
iron did not cause H202-dependent DNA damage. 
Hz02 alone, even at 1 mM, was also without 
effect. 
Because hydroxyf radical is known to be a pro- 
duct of the reaction of either Fe2+ or, less efficient- 
350 400 450 500 550 600 650 700 
WAVELENGTH bml 
Fig.2 Titration of adri~ycin and ll-deoxyadrjamycin with FeCl 3. The final concentration of the anthracyc~ine 
antibiotic in the assay was 30 &I. (A) Curve 1, adriamycin alone, curves 2,3,4 and 5, 12: 1, 6: 1, 4: 1 and 3 : 1 
anthracycline/metal ion ratios, respectiveiy. (B) Curve I, 1 i-deoxyadriamycin alone; curves 2 and 3, 6: I and 3: 1 
drug/iron ratios. 
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Fig.3. HzOz-dependent DNA damage induced by 
anthracycline-iron complexes. (X---X) Adriamycin- 
Fe3+, (M) 1 I-deoxyadriamycin and Fe3+. 
ly, Fe3+ with HzOz, spin-trapping studies were car- 
ried out to detect this species. Addition of Hz02 to 
adriamycin solutions in the presence of DMPO 
produced no detectable ESR signal. However, 
when Hz02 was added to the adriamycin-Fe3+ 
complex, a small but detectable ESR spectrum 
consisting of a 1: 2 : 2 : 1 quartet was observed. The 
hyperfine splitting constants for this DMPO ad- 
duct were aN = 8 = 14.9 G, which are identical to 
those of a DMPO-OH adduct resulting from the 
trapping of ‘OH [6]. Moreover, formation of the 
DMPO-OH adduct was significantly decreased in 
the presence of either ethanol (0.22 mM) or DMSO 
(0.14 mM). These observations suggest that the 
adriamycin-Fe3+ complex catalyzed the formation 
of ‘OH in the presence of Hz02 and that the 
DMPO-OH adducts observed did not arise from 
the decomposition of DMPO-OOH as shown in 
171. In the presence of DNA, the adriamycin-Fe3+ 
complex significantly stimulated the formation of 
hydroxyl radicals from Hz02 (fig.4). Moreover, 
the concentration of ‘OH radicals as measured by 
monitoring the signal intensity of the low-field line 
of the DMPO-OH adduct spectrum increased with 
time and reached a maximum in I5 min. The abili- 
ty of DNA to stimulate hydroxyl radical formation 
by the adriamycin-iron complex correlates with 
the ability of the adriamycin-iron chelate to form 
a stable ternary complex with DNA which is itself 
Fig.4. ESR spectrum of the DMPO-OH spin adduct 
formed in the presence of lOOgg/ml calf thymus DNA 
and 90 FM HZOZ from (A) Fe3+ (10 PM), (B) adriamycin 
(10 PM)-Fe3+ (10 PM) and (C) 1 l-deoxyadriamycin 
(10 PM)-Fe3+ (10pM). ESR settings: field, 3390 G; 
field scan, 100 G; modulation frequency, 100 kHz; 
modulation amplitude, 2.0 G; microwave power, 
20 MW; and the receiver gain, 1.25 x 10’. 
an active redox catalyst. This is the opposite of the 
effect that DNA addition has on the microsomal 
reduction of adriamycin to a semiquinone radical, 
where DNA addition quenches radical formation. 
In contrast to the adriamycin-Fe3+ complex, the 
11 -deoxyadrianiycin-Fe3+ mixture, in the presence 
of DNA, was ineffective in stimulating the forma- 
tion of ‘OH from Hz02 (fig.4). Actually the 
1 I-deoxyadriamycin-Fe3+ mixture was no better 
than Fe3+ alone in catalyzing ‘OH formation from 
Hz02 in the presence of DNA, Thus, both in terms 
of H202-catalyzed DNA destruction and hydroxyl 
radical production 11 -deoxyadriamycin is marked- 
ly less efficient than adriamycin. 
Our results reveal that the DNA-iron-adriamy- 
tin complex can catalyze the production of hydro- 
xyl radicals from Hz02 under the same conditions 
in which this complex also causes DNA cleavage. 
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Table 1 
Hydroxyl radical formation and DNA damage catalyzed 
by anthracycline-Fe3+ complexes 
Reactant Relative OH % DNA 
formation damage= 
DNA-Fe3+ 
I I-Deoxyadriamycin + 
100 3.0 
Fe3+ + DNA 90 9.4 
Adriamycin + Fe3+ + DNA 533 84.0 
a In each case the reaction mixture contained 10pM 
Hz02 
For details ee section 2. Relative OH formation is given 
in arbitrary units based upon peak heights with the 
signal of DNA-Fe3+ set to 100 
Furthermore, the relative efficiency of adriamycin 
and 1 1-deoxyadriamycin-iron complexes as cata- 
lysts of hydroxyl radical production correlates with 
their effectiveness in the HzOz-dependent DNA 
cleavage reaction (table 1). When taken together 
with our observation that hydroxyl radical scaven- 
gers lessen the DNA damage [3], these results 
strongly suggest hat the DNA damage caused by 
adriamycin-Fe’+ complex in the presence of Hz02 
is mediated by the hydroxyl radical. The relative 
inefficiency of the hydroxyl radical scavengers, 
mannitol and DMSO, can now be explained by the 
fact that the site of hydroxyl radical generation is 
the DNA-bound drug-metal complex: the close 
proximity of source and DNA target makes any 
reaction of hydroxyl radical with the scavenger less 
likely. 
Finally, these results point to the critical role of 
the C11-hydroxyl group in iron binding. The lack 
of spectral shift on iron addition and the fact that 
DNA damage and hydroxyl radical production are 
equivalent o iron alone all suggests that 11 -deoxy- 
adriamycin does not chelate iron. This is consistent 
with a prediction we had made earlier based upon 
the X-ray crystal structure of daunomycin [S]. 
Briefly, the distance between the oxygens at Cl1 
and CIZ, but not between those at CS and Cg, is 
ideal for iron chelation. Based upon this, we 
predicted that the absence of the Cl1 hydroxyl 
would have drastic effects on the iron-chelating 
properties of adriamycin. Thus, the present results 
support the hypothesis that the iron-chelation site 
on adriamycin is between the hydroxyl at Cl1 and 
the carbonyl at Clz. We are now attempting to 
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